Peli BioThermal wins at Asia-Pacific bioprocessing awards

Published: 18-Mar-2021
Regulatory

This is the third year running Peli Biothermal has won at the awards

Peli BioThermal has been announced winner of the Best Temperature Control Packaging Provider - Passive category at the annual Asia-Pacific Bioprocessing Excellence awards 2021.

The company reportedly won the award for its high-performing passive packaging serving the biopharma industry.

Benson Teo, Peli BioThermal’s Senior Director of Sales, Asia, said: “We are honoured and delighted to win this third award in succession is a fantastic achievement. It is amazing to win an award for our outstanding passive packaging products, repeating our previous success in 2019 when we also won this award category.

“As the company expands its presence in Asia we are excited to accept this latest award which recognises our ongoing commitment to delivering excellence and innovation to the biologics sector in Asia and the rest of the world.”

The award was presented virtually at the 5th annual edition of the ceremony on 17th March 2021, which was reportedly attended by more than 500 representatives from Asian biologistics businesses.

  • Companies:
  • Peli BioThermal
See more

You may also like

Regulatory

Peli BioThermal announces global brand unification

Read more
The change to the company’s brand name takes effect immediately and a website will launch in the coming weeks, with further brand changes throughout 2021

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Peli BioThermal announces global brand unification

The change to the company’s brand name takes effect immediately and a website will launch in the coming weeks, with further brand changes throughout 2021
Regulatory

How global air cargo trends are reshaping pharmaceutical transport

As we welcome the new decade and the exciting advances it’s expected to unleash, many of the forces that shaped the past decade for transporting pharmaceuticals will continue. Price pressures, alternatives to air freight and increasing automation are just a few. However, there are emerging trends that make 2020 unique
Packaging

Cool Logistics achieves laboratory accreditation success

A first for a leading manufacturer of temperature-controlled packaging solutions
Regulatory

Accelerating and enhancing toxicology assessments

Infographic guides users through ToxHQ’s speedy assessment features
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535

Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
Regulatory

Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy

The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain

With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
Subscribe now